1. Are rising drug expenditures necessarily bad?
2. Is the high price of drugs determined by the high cost of developing a new drug?
3. Why do drug manufacturers charge different purchasers different prices for the same prescription drug?
4. What methods have managed care plans used to limit their enrollees' drug costs?
5. What is the consequence of the FDA providing the public with greater assurance that a new drug is safe?
6. What are "orphan" drugs, and why are drug firms less likely to develop such drugs today?
7. Why would a policy of re-importation of prescription drugs be ineffective?